Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Jul 17, 2024
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2024-07-15$11.72/sh−4,325$50,689→ 99,447 total
Holdings
- 1,911.27(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.
- [F2]Includes 1,009 shares acquired under the Phathom Pharmaceuticals, Inc. employee stock purchase plan in July 2024.